Global burden of traumatic brain and spinal cord injury
Traumatic brain injury (TBI) and spinal cord injury (SCI) are devastating conditions with far-reaching physical, emotional, and economic consequences for patients, families, and society at large. In The Lancet Neurology, the Global Burden of Diseases, Injuries, and Risk Factors (GBD) 2016 TBI and SCI Collaborators provide a rigorous and comprehensive analysis of the global, regional, and national burden of TBI and SCI from 1990 to 2016. 1 In addition to providing point estimates for the incidence, prevalence, and years of life lived with disability (YLD) of TBI and SCI by country, the Collaborators examine how these measures have changed with time. This Article has several important messages that merit close consideration.
First, the global age-standardised incidence (percentage change 3·6% [95% uncertainty interval 1·8-5·5]), prevalence (8·4% [7·7-9·2]), and YLD (3·6% [1·8-5·5]) rates for TBI rose significantly between 1990 and 2016. Although these rates did not change significantly for SCI between 1990 and 2016, the total number of patients living with SCI is also likely to be increasing because the global population is increasing. The main causes of these injuries across most geographical locations were falls and road traffic accidents, suggesting that interventions targeting fall prevention and improved road safety should be key public health priorities. Furthermore, policy makers and governments should be prepared to invest resources into centres specialising in multidisciplinary care for people with TBI or SCI, because available systems are likely to become overburdened. Infrastructural changes at a health-care-systems level might be necessary to establish appropriate clinical care pathways and improve timely access to quality care.
Second, although the age-standardised incidence of TBI in 2016 was nearly 30 times greater than that of SCI (369 per 100 000 vs 13 per 100 000), the agestandardised prevalence of TBI was only about double that of SCI (759 per 100 000 vs 368 per 100 000), and the age-standardised YLD rate for TBI was lower than that of SCI (111 per 100 000 vs 130 per 100 000). These differences between TBI and SCI are probably because of the higher case-fatality rate of TBI (ie, higher acute mortality from injury), although this effect should at least be partly offset by the higher standardised mortality ratios for SCI (ie, poorer long-term life expectancy for those who survive SCI).
2,3 Nonetheless, we can reasonably conclude from these data that the long-term burden of SCI for patients, caregivers, healthcare systems, and the economy exceeds that of TBI.
Third, this study showed that the age-standardised incidence and prevalence of SCI remained stable globally from 1990 to 2016. However, with demographic shifts, the overall pattern and morphology of these injuries are likely to have changed despite stability in the overall incidence, and such changes in distribution might vary by geographical region. Therefore, it would be prudent to examine how the age composition and patterns and mechanisms of injury among patients with SCI (and TBI) have changed over time and across different locations. A US study, 4 for example, showed that the mean age of patients who had an SCI rose from 40 years in 1993 to 50 years in 2012. An increasing proportion of injuries occurred in older patients (ie, ≥65 years) secondary to falls. 4 Similar trends have been reported in other highincome countries, both for SCI 5, 6 and TBI. 7 This shift in the demographics of SCI and TBI is important because the acute care and rehabilitation of older patients with SCI or TBI present unique challenges, the health-care resources consumed are greater, and the outcomes are poorer than those in young patients. 8, 9 For example, older patients often have substantial comorbidities, and hence might be less able than younger patients to tolerate the extensive surgeries that can be indicated for severe SCI or TBI. 10 The GBD 2016 TBI and SCI Collaborators' study was made possible by the resources and wealth of information contained within the GBD 2016 frame work, and makes use of all accessible data, including in patient and outpatient health records, literature studies, and survey data. The uniform modelling strategy (based on Bayesian algorithms) and calculation of age-standardised epidemiological estimates permit comparisons between countries with different popula tion distributions. Limitations include potential under estimation of the true incidence of TBI, as the authors point out, because of the failure to capture cases of mild TBI or concussion in patients who do not seek medical care. Furthermore, without stratification of SCI severity-eg, by the American Spinal Injury Association Impairment Scale (AIS) or Frankel grading-the true burden of disability attributable to SCI is difficult to appreciate fully. The consequences of an AIS grade A (ie, complete) SCI, for example, are very different from those of an AIS grade D injury. With additional data from large regional, national, and international registries of patients with SCI, we hope that future iterations of this study will be appropriately positioned to provide more accurate and granular estimates of the burden of SCI.
All in all, the GBD 2016 TBI and SCI Collaborators' study is a formidable undertaking and the authors are to be congratulated for this important contribution to the literature. This study serves as a sobering reminder that, despite improvements in access to, and quality of, trauma care, the effects of neurotrauma continue to loom large on a global scale. We hope, however, that, by illuminating the ongoing and profound effects of TBI and SCI internationally, studies such as this one will inspire and invigorate clinicians, researchers, and policy makers to redouble efforts to develop improved prevention and treatment strategies. 
